Seizing opportunity at the limits of medicine : an enhanced definition of innovative practice [Separata] /

The activity of innovative practice relates to seizing opportunities now for patients in desperate situations and the ethical dilemmas around it. Sadly, the term innovation has multiple meanings, adding confusion and misunderstanding to an already difficult debate. This paper aims to enhance the def...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Mastroleo, Ignacio
Otros Autores: Holzer, Felicitas
Formato: Capítulo de libro
Lenguaje:Inglés
Materias:
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 02773naa a2200301 a 4500
003 AR-BaFLA
005 20201221150104.0
008 191113t2019 sz ||||fs ||| 001 0 eng d
999 |c 47603  |d 47603 
040 |a FLACSO Argentina  |c FLACSO Argentina 
041 0 |a eng 
100 1 |9 19323  |a Mastroleo, Ignacio 
245 1 0 |a Seizing opportunity at the limits of medicine :   |b an enhanced definition of innovative practice [Separata] /   |c Ignacio Mastroleo and Felicitas Holzer  |h DIG 
300 |a pp. 1-44 
336 |2 rdacontent  |a Texto  |b txt 
337 |2 rdamedia  |a computadora  |b c 
338 |2 rdacarrier  |a Recurso el línea  |b cr 
504 |a incl. ref. 
520 |a The activity of innovative practice relates to seizing opportunities now for patients in desperate situations and the ethical dilemmas around it. Sadly, the term innovation has multiple meanings, adding confusion and misunderstanding to an already difficult debate. This paper aims to enhance the definition of innovative practice in two ways. Fist, we propose to curb ambiguity by replacing the term "innovative practice" with the more precise of "new non-validated practice" and by distinguishing the specific meaning of innovation at stake. To identify this meaning, we analyse the traditional research ethics’ distinction between research, validated practice, and innovation. Second, we propose the following unified definition of "new non-validated practice", that is, the first or recent use of diagnostic, therapeutic or preventive interventions that introduce a significant change (new); with an insufficient level of evidence of safety or efficacy for regular healthcare (non-validated); and with the main aim to benefit patients (practice). To avoid objections to our definition, we analyse its three core elements (significant novelty, insufficient validation for, and patients' best interests) and we present a 2D classification of medical practice that follows from our definition. If sound, our enhanced definition of "new non-validated practice" allows comparing exceptional activities in different fields of medicine that previously have been considered unconnected (e.g. compassionate use of investigational drugs, humanitarian uses of devices, novel off-label uses, etc.). In turn, it also provides a promising conceptual tool to inform empirical research, discuss responsible access to innovative care and evaluate the regulation of innovative practice (e.g. right-to-try laws). 
650 4 |9 10121  |a ETICA MEDICA 
650 4 |9 6439  |a MEDICINA 
650 4 |9 12828  |a INNOVACION CIENTIFICA 
650 4 |9 3806  |a INNOVACIONES 
650 4 |9 275  |a ESTUDIOS DE CASOS 
690 |a BIOETICA 
700 1 |9 33576  |a Holzer, Felicitas 
773 |d Bern : Preprints, 2019  |t Preprints  |x 2310-287X 
942 |c ART